China National Accord Medicines (SZSE:000028) Future 3-5Y EPS without NRI Growth Rate : 9.63 (As of Jul. 27, 2024)

View and export this data going back to 1993. Start your Free Trial

What is China National Accord Medicines Future 3-5Y EPS without NRI Growth Rate?

Future 3-5Y EPS without NRI Growth Rate is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

As of today, China National Accord Medicines's Future 3-5Y EPS without NRI Growth Rate is 9.63.

Competitive Comparison of China National Accord Medicines's Future 3-5Y EPS without NRI Growth Rate

For the Medical Distribution subindustry, China National Accord Medicines's Future 3-5Y EPS without NRI Growth Rate, along with its competitors' market caps and Future 3-5Y EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

China National Accord Medicines's Future 3-5Y EPS without NRI Growth Rate Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, China National Accord Medicines's Future 3-5Y EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where China National Accord Medicines's Future 3-5Y EPS without NRI Growth Rate falls into.

China National Accord Medicines (SZSE:000028) Future 3-5Y EPS without NRI Growth Rate Explanation

Future 3-5Y EPS without NRI Growth Rate s the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average earnings per share (EPS) estimates growth rate.

China National Accord Medicines Future 3-5Y EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of China National Accord Medicines's Future 3-5Y EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

China National Accord Medicines Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » China National Accord Medicines Corp Ltd (SZSE:000028) » Definitions » Future 3-5Y EPS without NRI Growth Rate

Comparable Companies

Traded in Other Exchanges

200028:China

Address

No. 15, Ba Gua Si 4th Road, Accord Pharmaceutical Building, Futian District, Guangdong Province, Shenzhen, CHN, 518029

Website

http://www.szaccord.com.cn

China National Accord Medicines Corp Ltd develops and manufactures pharmaceuticals in China. The company engaged in the wholesale of Chinese patent drugs, traditional Chinese medicines, chemical medicine preparations, antibiotics, biochemical drugs and cerebrovascular system drugs. It operates through the following segments: The Head office segment engages in investing and managing the business; The Pharmaceutical Distribution segment engages in the distribution of medicine and pharmaceutical products to customers, including hospitals, other distributors, retail drug stores, and clinics, and Retail pharmacy segment, which is managing the operation of Guoda Pharmacy. It generates maximum revenue from the Pharmaceutical Distribution segment.

Executives

Su Wei Wei	Independent director
Chen Chang Bing	Secretary Dong
Peng Juan	Director
Fu Ming Zhong	Director

China National Accord Medicines Headlines

No Headlines